BioCentury
ARTICLE | Financial News

Harvard's Wyss launches gene imaging newco ReadCoor

September 29, 2016 7:00 AM UTC

ReadCoor Inc. (Boston, Mass.) debuted with $23 million in a series A round to develop and commercialize fluorescent in situ sequencing (FISSEQ) technology from the Wyss Institute for Biologically Inspired Engineering at Harvard University.

Decheng Capital led the round. Lilly Asia Ventures, Vivo Capital and Hansjoerg Wyss also participated. ...